Eli Lilly

Scott Galloway: Why I'm selling my American stocks

My First Million

Pharmaceutical company cited alongside Novo Nordisk as a GLP-1 drug supplier; referenced in the same policy discussion.

Big Pharma and the Big Lie – The Chemical Imbalance Theory of Mental Illness

Academy of Ideas

The All-In Holiday Spectacular

All-In Podcast

David Ricks, its CEO, is recognized for building a billion-dollar company and being unstoppable.

Markets turn Trump, Long rates spike, Election home stretch, Influencer mania, Saving Starbucks

All-In Podcast

A pharmaceutical company whose stock performance (representing anti-sugar trends) is compared positively against Starbucks, suggesting a market shift towards health.

Dave Ricks, CEO of Eli Lilly | The All-In Interview

All-In Podcast

A pharmaceutical company discussed as the world's most valuable, leading the GLP-1 drug market, and experiencing significant growth in market cap and revenue.

The Science of Hunger & Medications to Combat Obesity | Dr. Zachary Knight

Andrew Huberman

The pharmaceutical company that makes the GLP-1/GIP dual agonist tirzepatide (Mounjaro/Zepbound) and is developing a triple agonist.